Meningitis Diagnostic Testing Market - Forecast(2021 - 2026)

Report Code: HCR 0827 Report Format: PDF + Excel (Delivery in 48 Hrs)

Meningitis Diagnostic Testing Market Overview

Meningitis Diagnostic Testing Market size is estimated to reach $600 million by 2026, growing at a CAGR of 5% over 2021-2026. Meningitis is an inflammation (swelling) of the protective membranes, called meninges that covers the brain and spinal cord. Meningitis diagnostic tests include tests such as latex agglutination tests, imaging, or spinal tap and the cerebrospinal fluid test is also used to detect meningitis. Moreover, meningitis can be caused owing to an ear sinus infection, a skull fracture, or after some surgeries. Increasing prevalence of infectious disease and HIV (Human Immunodeficiency Virus) and rising technological advancements are the major factor driving the growth of this market. Furthermore, rising research and development activities to diagnose the various type of meningitis is set to further enhance the overall market demand for Meningitis Diagnostic Testing Market for the period 2021-2026.

Meningitis Diagnostic Testing Market Report Coverage

The report: “Meningitis Diagnostic Testing Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Meningitis Diagnostic Testing Market. 

By Test Type: Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test, and Others

By Causative Agents: Bacteria, Virus, and Fungi

By End-Use Industry: Hospital, Diagnostic Center, and Others

By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, and Others), and Rest of the World (Middle East, Africa)

Key Takeaways

  • Geographically, in 2020 North America dominated the Meningitis Diagnostic Testing Market owing to increasing adoption of advanced diagnostic devices, and easy availability of diagnostic test kits.
  • Increasing prevalence of infectious disease and HIV and rising technological advancements are likely to aid in the market growth of the Meningitis Diagnostic Testing Market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Meningitis Diagnostic Testing Market report.
  • Lack of skilled workers and lack of awareness regarding of diagnosis is set to create hurdles for the Meningitis Diagnostic Testing Market.

Meningitis Diagnostic Testing Market Segment Analysis- By Test Type

The global Meningitis Diagnostic Testing Market based on Test Type can be further segmented into Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test, and others. The PCR Assay segment is the major segment generating revenue in 2020. This is owing to the high ability of PCR to diagnose the disease within a short time period and provide accurate results. The Lateral Flow Assay segment is estimated to register the fastest CAGR of 3.5% for the period 2021-2026. This is owing to increasing use of home based test, lesser price and rapid results.

Meningitis Diagnostic Testing Market Size, By Test Type

2020-2026 (USD Million)


  
   

Meningitis Diagnostic Testing Market Segment Analysis- By End Use

The global Meningitis Diagnostic Stents Market based on End-Use Industry can be further segmented into Hospital, Diagnostic Center, and Others. The Hospital segment registerd for the highest market share in 2020. This is owing to the increasing advanced diagnostic infrastructure and availability of skilled doctors. The Diagnostic Center segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is owing to availability of well equipped with sophisticated instruments increases preference towards diagnostic center.

Meningitis Diagnostic Testing Market Segment Analysis- By Geography

North America dominated the Meningitis Diagnostic Testing Market with major share of 45% in 2020. This is owing to increasing adoption of advanced diagnostic devices, increased number of diagnostic centers, and easy availability of diagnostic test kits. According to Joint United Nations Programme on HIV/AIDS (UNAIDS), about 37.9 million people suffering from HIV in 2018 which increasing the growth of Meningitis Diagnostic Testing Market of this region.

However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR of 20% during the forecast period 2021-2026 owing to the increasing incidence of infectious disease, the introduction of new and cost-effective stents by the key players in this region.

Meningitis Diagnostic Testing Market Drivers 

Increasing Prevalence of Infectious Disease and HIV

The increasing prevalence of infectious disease and HIV is increasing the growth of the Meningitis Diagnostic Testing Market. According to World Health Organization (WHO), about 38 million people have HIV in 2020 which increases the number of meningitis. Thus, increasing the growth of the Meningitis Diagnostic Testing Market over 2021-2026.

Technological Advancement

Rising technological advancement and rising healthcare sector is increasing the growth of the Meningitis Diagnostic Testing Market. Moreover, new advanced technologies such PCR and next-generation sequencing are providing a less expensive way for the diagnosis which increases the growth of Meningitis Diagnostic Market over 2021-2026.

Meningitis Diagnostic Testing Market Challenges

Lack of Skilled Workers and Lack of Awareness Regarding Diagnosis

Some of the factors that is set to impede the growth of the Meningitis Diagnostic Testing Market are the absence of skilled workers and lack of access to newer diagnostic technologies. Moreover, lack of diagnostic laboratory infrastructure is set to create hurdles for the Meningitis Diagnostic Testing Market.

Covid Impact:

During COVID-19 Pandemic, the advancement in diagnosis and treatment of meningitis is increasing. This is owing to the entire healthcare industry are under pressure to improve the condition of this situation that are increasing the growth of this market. Moreover, there is no research to suggest that people who have suffered from meningitis are more likely to get coronavirus or become seriously ill from COVID-19. However, Medical Professional are getting more indication for the treatment of meningitis by the development of this diagnostic test and are contributing the growth of this market.

Meningitis Diagnostic Testing Market Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Meningitis Diagnostic Testing Market. Key companies of this market include B. Braun Melsungen AG, Sanofi, Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline plc, Merck KGaA, Baxter, Abbott, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Luminex Corporation, F. Hoffman-La Roche Ltd., Cepheid, and Pfizer Inc.

Acquisitions/Product Launches

  • In May 2019, Matinas Biopharma Holding Inc. recently announced the results from preclinical animal models to evaluate MAT2203 for the treatment of cryptococcal meningitis.

Relevant Reports :

Infectious Disease Testing Market

HCR 0085

Point-of-Care Infectious Disease Diagnostics/Testing Market

HCR 41046


For more Lifesciences and Healthcare Market reports, please click here

1. Meningitis Diagnostic Testing Market Overview
    1.1 Definitions and Scope
2. Meningitis Diagnostic Testing Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Test Type
    2.3 Key trends by Causative Agents
    2.4 Key trends by End-Use Industry
    2.5 Key trends by Geography
3. Meningitis Diagnostic Testing Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Meningitis Diagnostic Testing Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Meningitis Diagnostic Testing Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Meningitis Diagnostic Testing Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Meningitis Diagnostic Testing Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Meningitis Diagnostic Testing Market – By Test Type (Market Size -$Million/$Billion)
    8.1 Latex Agglutination Tests
    8.2 Lateral Flow Assay
    8.3 PCR Assay
    8.4 ELISA Tests
    8.5 Culture Test
    8.6 Others
9. Meningitis Diagnostic Testing Market – By Causative Agents (Market Size -$Million/$Billion)
    9.1 Bacteria
    9.2 Virus
    9.3 Fungi
10. Meningitis Diagnostic Testing Market – By End-Use Industry (Market Size -$Million/$Billion)
    10.1 Hospitals
    10.2 Diagnostic Center
    10.3 Others
11. Meningitis Diagnostic Testing Market - By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.7 Russia
        11.2.8 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Meningitis Diagnostic Testing Market Entropy
13. Meningitis Diagnostic Testing Market- Industry / Segment Competition landscape Premium Premium
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Best Practices for Companies
14. Meningitis Diagnostic Testing Market - Key Company List by Country Premium Premium
15. Meningitis Diagnostic Testing Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 Company 1
    15.3 Company 2
    15.4 Company 3
    15.5 Company 4
    15.6 Company 5
    15.7 Company 6
    15.8 Company 7
    15.9 Company 8
    15.10 Company 9
    15.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.